NCT02772003 2026-03-19
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection
National Cancer Institute (NCI)
Phase 1 Active not recruiting
Clinical Trials
4 trialsNCT03491683 2026-03-19
INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)
Inovio Pharmaceuticals
Phase 1/2 Active not recruiting
NCT04367675 2026-02-23
INO 5401 Vaccination in BRCA1/2 Mutation Carriers
Abramson Cancer Center at Penn Medicine
Phase 1 Active not recruiting
NCT03502785 2025-07-10
INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma
Inovio Pharmaceuticals
Phase 1/2 Completed